Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-29 Sale |
2025-05-30 5:00 pm |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
3,932 | $35.94 | $141,316 | 36,068 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-30 Option Award |
2025-06-03 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2025-05-28 Exercise |
2025-05-30 5:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
10,000 | $0 | 36,068 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
79,167 | $0 | 79,167 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 5:35 pm |
N/A 2034-10-16 |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
18,333 | $0 | 18,333 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-29 4:15 pm |
N/A 2034-05-28 |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |